What Do Stem Cell and Exosome Therapies Offer in Andrology? | Doç. Dr. Zülfü Sertkaya
Confidential, physician-led andrology assessment
Book Appointment
TRTürkçe ENEnglish

What Do Stem Cell and Exosome Therapies Offer in Andrology?

Do stem cell and exosome applications really work in erectile dysfunction? An honest account of how they are meant to work, where the scientific evidence stands today and how they relate to proven treatment steps.

One of the most asked-about subjects in andrology in recent years is regenerative treatment: stem cells, exosomes, PRP, shock wave. While bold claims about these methods circulate online, what the patient needs most is not exaggeration but a realistic framework. The purpose of this article is to set out honestly what these applications aim to do and where the scientific evidence stands today.

What does regenerative andrology aim for?

Most treatments for erectile dysfunction are directed at supporting current function: oral medication strengthens the vascular response, injections produce an erection directly. Regenerative approaches make a different claim: to repair the tissue itself and, by improving vascular structure and nerve function, to support the basis of function. The goal is ambitious and exciting; but the scale of the goal does not mean the outcome has been proven.

How are stem cell therapies applied in andrology?

Stem cells are cells able to differentiate into various cell types and to produce signals that support tissue repair. In andrology, cells obtained from the patient's own fat tissue or bone marrow are most often used; the prepared product is applied to penile tissue. The aim is to support repair of the vascular lining and smooth muscle tissue and to limit fibrosis (hardened scar tissue). The same rationale is also being investigated in conditions such as Peyronie disease and chronic prostatitis.

What are exosomes and how do they differ from stem cells?

Exosomes are very small vesicles secreted by cells, carrying proteins and genetic signalling molecules. In short, they are the message packets cells send to one another. Exosome-based approaches use not the cell itself but these signal packets. Their theoretical advantage is avoiding some of the problems that come with transferring living cells and making a standardisable product possible. However, this field is newer than stem cell therapy and the accumulation of clinical data is more limited.

Where does the scientific evidence stand today?

The honest answer is this: these methods are at the research stage. Some published studies report encouraging results; however, most involve small numbers of patients, follow-up periods are short, and application protocols vary from centre to centre. Consequently:

  • Regenerative treatments have not replaced the standard first-line treatments for erectile dysfunction
  • There is as yet no agreed protocol on who should be treated, at what dose and for how many sessions
  • No reliable criterion has been defined to predict which patient group will benefit

This picture does not mean the methods are worthless; it means they are still maturing. The task of a doctor following the field is to set expectations correctly without extinguishing hope.

Who may be considered for them?

Regenerative applications generally come onto the agenda for the following profiles: patients with mild-to-moderate, vascular erectile dysfunction; those with a partial response to oral medication; and those who wish to support the tissue before a surgical procedure. By contrast, expectations should be kept low in patients with advanced vascular damage, long-standing uncontrolled diabetes or seriously impaired nerve integrity. The decision is made by considering examination, any indicated imaging and the patient's response to previous treatments together.

What do these treatments not promise?

Perhaps the most important thing a doctor should say on this subject is what is not promised. Regenerative applications should not be presented as methods that report results in everyone, that produce improvement in a single session, or that remove the need for surgery in advanced cases. Nor is it correct to associate them with expectations such as increased length or girth. If you encounter an account in which the outcome is stated in advance, that is not a scientific approach.

Where do the proven steps stand?

The treatment steps in erectile dysfunction are well established, and regenerative approaches do not replace them but are considered alongside them:

  1. Lifestyle and management of coexisting conditions: diabetes, blood pressure, sleep and smoking. This is often the most overlooked step.
  2. Oral medication (PDE5 inhibitors): first-line medical treatment.
  3. Injection therapies and vacuum devices: effective options in patients who do not respond.
  4. Penile prosthesis: the surgical solution that reliably restores function in patients who gain insufficient benefit from the other steps.

For now, regenerative methods are a complementary field that supports these steps and is considered in selected patients. The right question is not is this treatment good but what can this treatment do in my particular case — and only an individual assessment can answer it.

Assoc. Prof. Zülfü Sertkaya, one of Europe's leading high-volume penile implant surgeons, holds Boston Scientific AMS 700™ and Coloplast Titan® centre of excellence credentials and performs surgery using the no-touch technique, in which the prosthesis is placed without contact with the skin. At his clinic in Istanbul all assessments are carried out with full confidentiality.

Frequently Asked Questions

These methods are at the research stage. Although some studies report encouraging results, patient numbers are limited and follow-up periods are short. Stem cell applications have therefore not replaced standard first-line treatments; they are considered as a complementary option in selected patients.
Stem cell treatment uses the cell itself; the exosome approach uses the small vesicles secreted by cells, which carry proteins and genetic signalling molecules. The exosome field is newer and the accumulation of clinical data is more limited.
Such an expectation is not realistic in advanced cases. Regenerative approaches are mainly considered in mild-to-moderate, vascular cases. In patients who gain insufficient benefit from the other steps, a penile prosthesis remains the option that reliably restores function.
Application protocols vary from centre to centre, and there is as yet no agreed standard on the number of sessions or the dose. This uncertainty makes it all the more important to discuss expectations openly with your doctor before starting treatment.
Medical Disclaimer: The content on this page is for general information only and does not replace a physician's examination. Always consult a doctor for a personal diagnosis and treatment.
ED Assessment Form PE Assessment Form Chat With Us